what cryptocurrency is all about- Top Overview

According to sources, Hamas's demand for a ceasefire in the Israeli Gaza has been relaxed, and a hostage agreement is expected to be reached. According to sources, Hamas will now agree to let the Israeli army stay temporarily after the fighting stops.The Nikkei 225 index closed at 39,881.10 points in early trading, up 1.29%.Ministry of Human Resources and Social Security and other five departments: Since December 15th, the personal pension system has been pushed from 36 pilot cities (regions) to the whole country, and the Ministry of Human Resources and Social Security and other five departments have issued the Notice on the Full Implementation of the Personal Pension System. Since December 15th, the personal pension system has been extended from 36 pilot cities (regions) to the whole country. The so-called personal pension is a supplementary old-age insurance system with voluntary participation, market-oriented operation and national policy support. Individuals voluntarily deposit a sum of money in a specific account, which does not exceed 12,000 yuan per year. Different from ordinary bank wealth management, funds and commercial insurance, individual pensions can enjoy the preferential policy of deferred taxation. In order to promote the preservation and appreciation of individual pensions, the circular requires optimizing product supply, and on the basis of existing financial products such as wealth management products, savings deposits, commercial pension insurance and Public Offering of Fund, specific pension savings and index funds will be included in the catalogue of individual pension products. (Xinhua News Agency)

The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.China Seismological Network officially determined that an earthquake of magnitude 5.2 occurred in Fiji Islands (14.95 degrees south latitude and 178.15 degrees west longitude) at 09: 51 on December 12, with a focal depth of 10 kilometers.The National Green Development Fund and other companies have established ecological restoration production and investment partnerships. According to the enterprise survey APP, recently, Jiangxi Green Gold Ecological Restoration Industry Investment Partnership (Limited Partnership) was established with a capital contribution of 1 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the company is jointly owned by National Green Development Fund Co., Ltd. and Jiangxi Jinkong Investment Group Co., Ltd.

The yield of active 2-year treasury bonds dropped by 9BP to 1.16%, which was 9BP upside down from the current 1-year treasury bond yield. The yield of active 2-year treasury bonds dropped by 9BP to 1.16%, which was 9 BP upside down from the current 1-year treasury bond yield.The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.